Jim Cramer Likes Walmart, Recommends Buying This 'Very, Very Good' Financial Stock

On CNBC's “Mad Money Lightning Round,” Jim Cramer said he likes Walmart Inc. WMT.

According to a CNBC report, Walmart started providing body cameras to some of its store-level employees across the U.S. as part of a pilot program testing the technology.

Royalty Pharma plc RPRX is a “disappointing” stock, Cramer said. “I want you to stick with it, I would not get rid of the stock here, it's too good a company.”

On Nov. 6, Royalty Pharma reported quarterly earnings of $1.04 per share which beat the analyst consensus estimate of 93 cents per share. The company reported quarterly sales of $565.00 million which missed the analyst consensus estimate of $696.10 million.

Cramer said he doesn't want to own Magna International Inc. MGA. “The autos are the worst place to be,” he noted.

On Dec. 16, Wells Fargo analyst Colin Langan maintained Magna International with an Equal-Weight rating and lowered the price target from $46 to $44.

The “Mad Money” host recommended buying M&T Bank Corporation MTB, adding that it is a “very, very good” company.

M&T Bank will announce its fourth quarter and full-year 2024 earnings results before the market opens on Thursday, Jan. 16, 2025. Analysts expect the company to report quarterly earnings at $3.74 per share on revenue of $2.34 billion.

Price Action:

• Walmart shares fell 0.2% to settle at $93.40 on Thursday.
• Royalty Pharma shares fell 0.8% to close at $24.28 during the session.
• Magna International shares fell 1.6% to settle at $41.28 on Thursday.
• M&T Bank shares fell 0.4% to $185.42 on Thursday.

Read Next:

• Top 3 Consumer Stocks You May Want To Dump This Quarter

Photo: Shutterstock